Search -

Displaying 401 - 420 of 453

Sort: Relevancy | Date

Presentation TCT 2012

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

Presenter: Timothy Henry

October 23, 2012

Presentation TCT 2012

New Devices in the Old World: A European View of Device Development for Heart Failure

Presenter: Stefan Anker

October 23, 2012

Presentation TCT 2012

MitraClip in Patients with CHF

Presenter: Stephan Baldus

October 23, 2012

Presentation TCT 2012

Management of the Device Patient for the Non-EP MD

Presenter: Ralph Verdino

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Presenter: Martyn Thomas

October 23, 2012

Presentation TCT 2012

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

Presenter: Kimberly Selzman

October 23, 2012

Presentation TCT 2012

Counterpulsation with SYMPHONY for Chronic Heart Failure

Presenter: Robert Dowling

October 23, 2012

Presentation TCT 2012

Counterpulsation for Chronic Heart Failure: Sunshine

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

CorAssist

Presenter: Mitchell Krucoff

October 23, 2012

Presentation TCT 2012

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

CircuLite for Patients with INTERMACS 4, 5, and 6

Presenter: Daniel Burkhoff

October 23, 2012

Presentation TCT 2012

Circulatory Support for Cardiogenic Shock

Presenter: E. Magnus Ohman

October 23, 2012

Presentation TCT 2012

BioVentrix Minimally Invasive Reshaping of the Anterior Infarcted Heart

Presenter: Lon Annest

October 23, 2012

Presentation TCT 2012

Background Medical and Device Therapies for Patients with VADs

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Year in Review: Heart Failure Therapies

Presenter: Biykem Bozkurt

October 23, 2012

Presentation TCT 2012

Thoratec Percutaneous Heart Pump

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

SynCardia

Presenter: Marvin Slepian

October 23, 2012

Advertisement

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

New Devices in the Old World: A European View of Device Development for Heart Failure

MitraClip in Patients with CHF

Management of the Device Patient for the Non-EP MD

HFPEF: Overview of Pathophysiology and Therapies

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

Counterpulsation with SYMPHONY for Chronic Heart Failure

Counterpulsation for Chronic Heart Failure: Sunshine

CorAssist

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

CircuLite for Patients with INTERMACS 4, 5, and 6

Circulatory Support for Cardiogenic Shock

BioVentrix Minimally Invasive Reshaping of the Anterior Infarcted Heart

Background Medical and Device Therapies for Patients with VADs

Autologous Cardiac Stem Cells in VAD Patients

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Year in Review: Heart Failure Therapies

Thoratec Percutaneous Heart Pump

SynCardia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content